Eli Lilly to report results of trials via registry
The move comes amid criticism drug companies may hide negative results of clinical trials of their drugs and follows a lawsuit by New York Attorney General Eliot Spitzer against rival GlaxoSmithKline.
By on Aug 10, 2004The move comes amid criticism drug companies may hide negative results of clinical trials of their drugs and follows a lawsuit by New York Attorney General Eliot Spitzer against rival GlaxoSmithKline.
Spitzer claimed the company suppressed information about its antidepressant Paxil.
Glaxo, which denied the allegation, said it would create an electronic database to make data from its trials accessible.
Lilly said it will begin posting results of all human trials and announce the initiation of all late-stage trials.
Lilly said it will disclose results of early, mid-stage and late-stage trials once a drug has been approved. For trials conducted after the drug has been approved, the company will release results as soon as possible but no later than one year after the trial has been completed.